David Rubenson MS, MBA, directs the science communication firm nobadslides.com. He previously served as a Public Policy Analyst at the RAND Corporation and has had appointments at the UCLA Brain ...
David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments. David Mitchell, PharmD ...
The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway. 259 Prospect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results